Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?

Cancer therapies based on in vivo stimulation, or on adoptive T cell transfer of Vγ9Vδ2 T cells, have been tested in the past decades but have failed to provide consistent clinical efficacy. New, promising concepts such as γδ Chimeric Antigen Receptor (CAR) -T cells and γδ T-cell engagers are curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Künkele, Klaus-Peter, Wesch, Daniela, Oberg, Hans-Heinrich, Aichinger, Martin, Supper, Verena, Baumann, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226769/
https://www.ncbi.nlm.nih.gov/pubmed/32235616
http://dx.doi.org/10.3390/cells9040829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226769/
https://www.ncbi.nlm.nih.gov/pubmed/32235616
http://dx.doi.org/10.3390/cells9040829

Ejemplares similares